Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OPh-16010029Phase 4Recruiting
Phase 4 trial of Relinqing granules and ciprofloxacin in Urinary System Diseases ((none)) (5 arms), sponsored by Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. Primary endpoints: protocatechuic acid in plasma, gallic acid in plasma and 3 more. Started Nov 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OPh-16010029.